Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison M Goate

Showing results (81-90 of 289) with videos related to

Pageof 29
Sort By:
American Journal of Human Genetics|October 5, 2019
A Rare Variant Nonparametric Linkage Method for Nuclear and Extended Pedigrees with Application to Late-Onset Alzheimer Disease via WGS DataLinhai Zhao, Zongxiao He, Di Zhang, et al.
Proteomics. Clinical Applications|December 8, 2010
Identification and validation of novel CSF biomarkers for early stages of Alzheimer's diseaseYan Hu, Ava Hosseini, John S K Kauwe, et al.
Archives of Neurology|December 17, 2009
Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer diseaseJohn C Morris, Catherine M Roe, Elizabeth A Grant, et al.
European Journal of Human Genetics : EJHG|August 3, 2020
A quantitative trait rare variant nonparametric linkage method with application to age-at-onset of Alzheimer's diseaseLinhai Zhao, Zhihui Zhang, Sandra M Barral Rodriguez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisCarmen Romero Molina, Wen Yi See, Ruben Gomez-Gutierrez, et al.
Frontiers in Neuroscience|April 20, 2018
Evaluation of Gene-Based Family-Based Methods to Detect Novel Genes Associated With Familial Late Onset Alzheimer DiseaseMaria V Fernández, John Budde, Jorge L Del-Aguila, et al.
The AAPS Journal|March 13, 2009
Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discoveryHenry A Lester, Cheng Xiao, Rahul Srinivasan, et al.
Journal of Alzheimer'S Disease : JAD|July 17, 2010
Validating predicted biological effects of Alzheimer's disease associated SNPs using CSF biomarker levelsJohn S K Kauwe, Carlos Cruchaga, Sarah Bertelsen, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|December 3, 2009
MAOA-uVNTR and early physical discipline interact to influence delinquent behaviorAlexis C Edwards, Kenneth A Dodge, Shawn J Latendresse, et al.
Archives of Neurology|December 14, 2005
Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of lifeB Joy Snider, Joanne Norton, Mary A Coats, et al.
Pageof 29

Showing results (81-90 of 289) with videos related to

Sort By:
Pageof 29
American Journal of Human Genetics|October 5, 2019
A Rare Variant Nonparametric Linkage Method for Nuclear and Extended Pedigrees with Application to Late-Onset Alzheimer Disease via WGS DataLinhai Zhao, Zongxiao He, Di Zhang, et al.
Proteomics. Clinical Applications|December 8, 2010
Identification and validation of novel CSF biomarkers for early stages of Alzheimer's diseaseYan Hu, Ava Hosseini, John S K Kauwe, et al.
Archives of Neurology|December 17, 2009
Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer diseaseJohn C Morris, Catherine M Roe, Elizabeth A Grant, et al.
European Journal of Human Genetics : EJHG|August 3, 2020
A quantitative trait rare variant nonparametric linkage method with application to age-at-onset of Alzheimer's diseaseLinhai Zhao, Zhihui Zhang, Sandra M Barral Rodriguez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisCarmen Romero Molina, Wen Yi See, Ruben Gomez-Gutierrez, et al.
Frontiers in Neuroscience|April 20, 2018
Evaluation of Gene-Based Family-Based Methods to Detect Novel Genes Associated With Familial Late Onset Alzheimer DiseaseMaria V Fernández, John Budde, Jorge L Del-Aguila, et al.
The AAPS Journal|March 13, 2009
Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discoveryHenry A Lester, Cheng Xiao, Rahul Srinivasan, et al.
Journal of Alzheimer'S Disease : JAD|July 17, 2010
Validating predicted biological effects of Alzheimer's disease associated SNPs using CSF biomarker levelsJohn S K Kauwe, Carlos Cruchaga, Sarah Bertelsen, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|December 3, 2009
MAOA-uVNTR and early physical discipline interact to influence delinquent behaviorAlexis C Edwards, Kenneth A Dodge, Shawn J Latendresse, et al.
Archives of Neurology|December 14, 2005
Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of lifeB Joy Snider, Joanne Norton, Mary A Coats, et al.
Pageof 29